Milwaukee-based Dohmen Company announced today it has acquired BioSoteria, a leading provider of drug safety and risk management services to the biopharmaceutical industry.
BioSoteria is based in Emeryville, Calif.
“As the industry paradigm shifts to one focused on the creation and approval of products for smaller, more targeted patient populations, the regulatory paradigm is also changing. Smaller patient populations mean fewer clinical trial participants and a greater commitment to post-marketing surveillance. Life Science companies need a business partner with deep knowledge and broad service capabilities in the areas of drug safety and pharmacovigilance, to help protect their promise of pharmaceutical care with the patients they serve. That’s the focus of this important service expansion strategy for Dohmen,” said chief executive officer Cynthia (Dohmen) LaConte.
LaConte said the Food and Drug Administration Amendments Act of 2007 which increased the FDA’s resources for more comprehensive reviews of new drugs and devices provided another catalyst for expert outsourced services.
“While this heightened regulatory scrutiny better protects American consumers, it also places increasing demands on life science companies. To meet clients’ needs, we founded DDN Medical Affairs in 2008, expanding our service capabilities in regulatory and safety services and offering outsourced product complaint and adverse event reporting services. Then, in 2011 we acquired MedComm Solutions in Emeryville, California to expand our services to include medical communications and clinical call center capability. Now, our acquisition of BioSoteria brings new support to life science companies by helping them create both pre-and post- marketing drug safety and risk management programs,” LaConte said.
BioSoteria president Sally Van Doren said, “We’re joining Dohmen because we’re impressed by Dohmen’s long-standing commitment to the future of healthcare, and because our proficiencies in drug safety, pharmacovigilance and risk management, combined with the varied service offerings of DDN Medical Affairs and MedComm Solutions will enable us to create a vanguard offering for the market.”
The latest acquisition advances Dohmen’s strategy of broadening the scope of its life science service offerings. Dohmen acquired three companies nationwide in 2011 and plans additional expansions in 2012.
